Standout Papers

<i>In vitro</i> Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevan... 2005 2026 2012 2019 797
  1. In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants (2005)
    Thomas O’Hare, Denise K. Walters et al. Cancer Research

Immediate Impact

3 by Nobel laureates 32 from Science/Nature 84 standout
Sub-graph 1 of 17

Citing Papers

Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
2023 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout

Works of Eric P. Stoffregen being referenced

Asynchronous Replication, Mono-Allelic Expression, and Long Range Cis-Effects of ASAR6
2013
In vitro Activity of Bcr-Abl Inhibitors AMN107 and BMS-354825 against Clinically Relevant Imatinib-Resistant Abl Kinase Domain Mutants
2005 Standout

Author Peers

Author Last Decade Papers Cites
Eric P. Stoffregen 1753 1383 1018 18 2.1k
Amie S. Corbin 1805 1348 861 27 2.4k
Ron Paquette 1716 1133 614 23 2.2k
Concepción Boqué 1946 1598 1006 23 2.2k
Ping Chen 1143 735 492 23 1.6k
Athena Countouriotis 1607 1391 924 21 1.9k
M. Brigid Bradley‐Garelik 2186 1832 1207 27 2.4k
Albert Hoenekopp 1574 1309 836 21 1.8k
J Groffen 1952 1297 506 18 2.6k
Franck E. Nicolini 2610 2053 1195 56 2.9k
Derek Norris 1001 720 488 19 1.7k

All Works

Loading papers...

Rankless by CCL
2026